SCHEMBL11233012

SCHEMBL11233012

CCc1[nH]c(=O)c(C(=N)NO)cc1-c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.42
PDE3A Q14432 1/20 0.42
CYP2E1 P05181 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2A6 P11509 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
NUDT1 P36639 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11229029 0.84 ALK (0.43) PDE3BPDE3ACYP2A6CYP2C19HDAC3
SCHEMBL11234641 0.84 PDE3B (0.44) PDE3BPDE3ACYP2E1CYP3A4CYP2A6
SCHEMBL11231128 0.83 MKNK1 (0.49) PDE3BPDE3AMKNK1MKNK2KMT2A
SCHEMBL11233016 0.80 PDE3B (0.41) PDE3BPDE3ACYP2E1CYP3A4CYP2A6
SCHEMBL11236586 0.80 CDK5 (0.53) PDE3BPDE3AKDM4EALDH1A1
SCHEMBL11236041 0.80 PDE3B (0.41) PDE3BPDE3ACYP3A4CYP2C9MKNK2
SCHEMBL11235886 0.79 PDE3B (0.46) PDE3BPDE3ACYP2E1CYP3A4CYP2A6
SCHEMBL11231551 0.79 AURKB (0.51) PDE3BPDE3ACYP2E1CYP3A4CYP2A6
SCHEMBL11230309 0.78 MKNK1 (0.49) PDE3BPDE3ACYP2E1CYP3A4CYP2A6
SCHEMBL10707484 0.76 PDE3B (0.73) PDE3BPDE3ACYP2E1CYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4339584-A Process for preparing 3-amino-5-(pyridinyl)-2(1H)-pyridinones via N-hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide by reaction with polyphosphoric acid STERLING DRUG INC. (US) 1982-07-13 US disclosed
US-4305948-A N-Hydroxy-1,2-dihydro-2-oxo-5-(pyridinyl)-nicotinimidamide and their cardiotonic use STERLING DRUG INC. (US) 1981-12-15 US disclosed